Roper Technologies Inc (ROP) Analysts See $2.30 EPS

Lloyd Doyle
October 13, 2017

Natixis Asset Management increased its position in shares of Roper Technologies by 11.3% in the third quarter. BlackRock Inc. lifted its holdings in Roper Technologies by 2,678.8% in the first quarter. It fall, as 36 investors sold Roper Technologies Inc shares while 202 reduced holdings. Lincoln Cap Limited Co invested in 0.15% or 1,000 shares.

Traders are feeling more bullish on shares of the company of late if you evaluate the change in short interest.

Trading volume for Roper Technologies, Inc. was 1,658 in the last trading session. It has outperformed by 6.40% the S&P500.

Tredegar Corporation (TG) formed multiple bottom with $17.86 target or 7.00% below today's $19.20 share price. Endologix, Inc. (ELGX) has $436.36 million valuation. Victory Capital Management owns 23,532 shares for 0% of their portfolio. Apptio Inc (NASDAQ:APTI) has 0.00% since October 12, 2016 and is. It has underperformed by 99.25% the S&P500. Vanguard Group Inc. now owns 10,856,231 shares of the industrial products company's stock worth $2,513,543,000 after purchasing an additional 354,064 shares during the period. Zacks Investment Research upgraded shares of Roper Technologies from a "hold" rating to a "buy" rating and set a $244.00 target price on the stock in a research note on Monday, May 1st. Therefore 90% are positive. Stifel Nicolaus reaffirmed a "buy" rating and issued a $242.00 target price on shares of Roper Technologies in a report on Friday, July 7th. The rating was maintained by RBC Capital Markets on Monday, May 1 with "Outperform". The firm has "Outperform" rating by RBC Capital Markets given on Tuesday, February 2. The company was maintained on Sunday, June 18 by Oppenheimer. The company was upgraded on Wednesday, September 20 by J.P. Morgan. Meag Munich Ergo Kapitalanlagegesellschaft Mbh has invested 0.78% in Roper Technologies Inc (NYSE:ROP). D E Shaw & has invested 0% in Roper Technologies Inc (NYSE:ROP). Royal Bankshares Of Canada reported 22,200 shares stake. The firm earned "Hold" rating on Thursday, July 27 by Canaccord Genuity. ROP's profit would be $234.27 million giving it 27.30 P/E if the $2.30 EPS is correct. After having $-0.18 EPS previously, Apptio Inc's analysts see 16.67% EPS growth.

Since June 9, 2017, it had 0 insider buys, and 1 sale for $411,661 activity. The days to cover decreased to 5.0 and the percentage of shorted shares was 0.02% on August 31. This represents a $1.40 dividend on an annualized basis and a yield of 0.56%. Also, Director Christopher Wright sold 500 shares of Roper Technologies stock in a transaction dated Tuesday, September 12th. State Of Alaska Department Of Revenue reported 2,278 shares. Westpac holds 33,356 shares. As of quarter end Fulton Bank, N.a. had disposed of a total of 2 shares trimming its stake by 9.1%.

Roper Technologies, a technology company. Pinebridge Invs L P holds 0.02% or 43,162 shares in its portfolio. The company had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.16 billion. Lmr Prtn Ltd Liability Partnership accumulated 7,153 shares or 0.1% of the stock. 21,437 were reported by Middleton And Ma.

Shares of Roper Technologies, Inc. Kbc Gp Nv accumulated 9,556 shares. 5,000 shares were bought by Zenty III Thomas F, worth $22,200. It also reduced Pimco Enhanced Short Maturity (MINT) stake by 11,680 shares and now owns 39,923 shares.

Among 3 analysts covering Tonix Pharmaceuticals Holding Corp. The rating was upgraded by Oppenheimer to "Outperform" on Friday, January 6. Therefore 100% are positive. Endologix Inc. has $20 highest and $5.0 lowest target. The stock was sold at an average price of $245.00, for a total value of $1,225,000.00. CSRA had 15 analyst reports since December 1, 2015 according to SRatingsIntel. RBC Capital Markets maintained Endologix, Inc. RBC Capital Markets has "Outperform" rating and $15 target. The rating was reinitiated by Jefferies with "Hold" on Thursday, October 5. Leerink Swann initiated the stock with "Mkt Perform" rating in Tuesday, September 6 report. RBC Capital Markets initiated Endologix, Inc. (NASDAQ:ELGX) rating on Thursday, August 6. The company now has a consensus rating of "Buy" and an average target price of $226.56.

Analysts await Endologix, Inc. It now has negative earnings.

Investors sentiment decreased to 0.82 in 2017 Q2. Ameriprise Incorporated, Minnesota-based fund reported 190,407 shares. Goldman Sachs has invested 0% in Endologix, Inc. The fund owned 29,354 shares of the industrial products company's stock after buying an additional 4,040 shares during the period. Bnp Paribas Arbitrage Sa holds 13,042 shares. Short shares fell from 1,976,931 to 1,754,208 over that timeframe. Barclays Public Limited Liability Co has invested 0% in Endologix, Inc. Meiji Yasuda Asset Mngmt Company accumulated 13,975 shares. Riverbridge Prtnrs Limited Liability Corporation accumulated 1,234 shares. Axa has invested 0.02% in Endologix, Inc.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article